SUN PHARMACEUTICAL INDUSTRIES,INC. — Dexamethasone Importer Profile
Pharmaceutical Importer · #4 buyer for Dexamethasone · $1.5M import value · 30 shipments · UNITED STATES · DGFT Verified
SUN PHARMACEUTICAL INDUSTRIES,INC. is the #4 importer of Dexamethasone from India with $1.5M in import value and 30 verified shipments. SUN PHARMACEUTICAL INDUSTRIES,INC. holds a 0.7% market share in Dexamethasone imports based in UNITED STATES. The company sources from 1 verified supplier across 12 formulations shipped to 1 country. Overall, SUN PHARMACEUTICAL INDUSTRIES,INC. imports 19 pharmaceutical products worth $33.2M across 10 therapeutic categories.
SUN PHARMACEUTICAL INDUSTRIES,INC. — Dexamethasone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Dexamethasone to SUN PHARMACEUTICAL INDUSTRIES,INC.?
Verified from 30 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.5M | 30 | 100.0% |
SUN PHARMACEUTICAL INDUSTRIES,INC. sources Dexamethasone from 1 verified Indian supplier based on 30 customs records. The primary supplier is SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100.0% of imports.
How Does SUN PHARMACEUTICAL INDUSTRIES,INC. Compare to Nearest Dexamethasone Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | MYLAN AUSTRALIA | AUSTRALIA | $1.9M | 53 | $35.4K |
| 11 | LLC SENTISS RUS | RUSSIA | $1.4M | 27 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC. ★ | UNITED STATES | $1.3M | 26 | $50.0K |
| 1 | DR REDDYS LABORATORIES INC | UNITED STATES | $1.2M | 24 | $50.0K |
| 2 | DR, REDDYS LABORATORIES, INC | UNITED STATES | $1.1M | 23 | $50.0K |
SUN PHARMACEUTICAL INDUSTRIES,INC. ranks #4 among 2,257 Dexamethasone importers from India. Average shipment value of $50.0K compared to the market average of $7.9K. The closest competitors by value are MYLAN AUSTRALIA and LLC SENTISS RUS.
Where Does SUN PHARMACEUTICAL INDUSTRIES,INC. Import Dexamethasone To?
Destination countries from 30 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.5M | 30 | 100.0% |
SUN PHARMACEUTICAL INDUSTRIES,INC. imports Dexamethasone to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.5M.
What Dexamethasone Formulations Does SUN PHARMACEUTICAL INDUSTRIES,INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA (BATCH NO AS PER INVOICE) | $373.4K | 8 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( | $250.0K | 5 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 (BATCH NO AS PER INVO | $150.0K | 3 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML USA (BATCH NO AS PER INVOICE)(55 SHI | $150.0K | 3 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 | $150.0K | 3 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML- USA PACK : 01*01 (BATCH NO AS PER INV | $100.0K | 2 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML- USA - PACK : 01*01 (BATCH NO AS PER I | $50.0K | 1 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML[PACK: 1X1] | $50.0K | 1 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML- USA - (BATCH NO AS PER INVOICE)(23 SHNOS | $50.0K | 1 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML- USA -(BATCH NO AS PER INVOICE)(106 SH | $50.0K | 1 |
SUN PHARMACEUTICAL INDUSTRIES,INC. imports 12 distinct Dexamethasone formulations from India. The top formulation is CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC S with 8 shipments worth $373.4K.
Regulatory Requirements: Importing Dexamethasone into United States
What SUN PHARMACEUTICAL INDUSTRIES,INC. and other importers must comply with to import Dexamethasone from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Dexamethasone
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Dexamethasone from India and How Much Does SUN PHARMACEUTICAL INDUSTRIES,INC. Import?
India exported $17.9M worth of Dexamethasone through 8,777 shipments from 808 suppliers to 176 countries, serving 2,257 buyers globally. SUN PHARMACEUTICAL INDUSTRIES,INC. imports $1.5M of this total, accounting for 0.7% of India's Dexamethasone exports with 30 shipments from UNITED STATES. This is verified from 30 customs shipment records covering 12 distinct formulations.
What Is the Average Order Value for SUN PHARMACEUTICAL INDUSTRIES,INC.'s Dexamethasone Imports?
SUN PHARMACEUTICAL INDUSTRIES,INC.'s average Dexamethasone order value is $49.1K per consignment, based on 30 shipments totaling $1.5M. SUN PHARMACEUTICAL INDUSTRIES,INC. is based in UNITED STATES and ranks #4 among all Dexamethasone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Dexamethasone to SUN PHARMACEUTICAL INDUSTRIES,INC.?
SUN PHARMACEUTICAL INDUSTRIES,INC. sources Dexamethasone from 1 verified Indian supplier: SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.5M, 100.0%). This is based on 30 customs records.
How Does SUN PHARMACEUTICAL INDUSTRIES,INC. Compare to Other Dexamethasone Importers?
SUN PHARMACEUTICAL INDUSTRIES,INC. ranks #4 among 2,257 Dexamethasone importers from India with a 0.7% market share. The top 3 importers are RX CROSSROADS 3PL LLC ($3.2M), EUGIA US LLC ($2.3M), MYLAN INSTITUTIONAL INC 2898 ($1.9M). SUN PHARMACEUTICAL INDUSTRIES,INC. processed 30 shipments from UNITED STATES.
About SUN PHARMACEUTICAL INDUSTRIES,INC.
SUN PHARMACEUTICAL INDUSTRIES,INC. imports 19 products worth $33.2M. Beyond Dexamethasone, top products include Mesalamine, Budesonide, Doxorubicin, Ipratropium, Amphotericin. View the complete SUN PHARMACEUTICAL INDUSTRIES,INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dexamethasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUN PHARMACEUTICAL INDUSTRIES,INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUN PHARMACEUTICAL INDUSTRIES,INC.'s capped import value divided by total capped export value for Dexamethasone across all Indian exporters.
- 5.Verified Records: This page is backed by 30 individual customs records matching SUN PHARMACEUTICAL INDUSTRIES,INC. importing Dexamethasone, covering 12 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,257+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dexamethasone Import Data for SUN PHARMACEUTICAL INDUSTRIES,INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for SUN PHARMACEUTICAL INDUSTRIES,INC.'s Dexamethasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN PHARMACEUTICAL INDUSTRIES,INC.
Full Company Profile →
19 products · $33.2M total trade · 10 categories
SUN PHARMACEUTICAL INDUSTRIES,INC. × Dexamethasone
Verified from customs records
Company Overview
Top Products by SUN PHARMACEUTICAL INDUSTRIES,INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUN PHARMACEUTICAL INDUSTRIES,INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dexamethasone. For current order-level data, contact TransData Nexus.